Contact
Contact
We are ZTL. Interested in piloting SOTA tools or forging partnerships? We're building robust algorithms for med's edge—clinicians, researchers, networks, let's align on advancing human vitality.
We are ZTL. Interested in piloting SOTA tools or forging partnerships? We're building robust algorithms for med's edge—clinicians, researchers, networks, let's align on advancing human vitality.
GET IN TOUCH
GET IN TOUCH
FAQ
FAQ
What is Zenith Tachyon Labs?
ZTL is a Texas S-Corp (est. 2025) building cloud-native SOTA AI tools for med's edge—empowering clinicians and researchers with secure, scalable insights that accelerate workflows and outpace diseases.
What makes ZTL's platform different?
Our patent-pending models deliver 95%+ accuracy on standard cloud infra (AWS/Render), HIPAA-compliant from day zero—rapid engineering for prototypes to pilots, no heavy hardware or legacy lock-in.
Are pilot opportunities available?
Yes—stealth pilots launching Jan 2026 with experts; apply via contact form or email us at info@zenithtachyon..com, targeting 5-10 sites by mid 2026 with diverse datasets for validation.
Contact ZTL?
Drop a vector via the form—reply in 48h on pilots, collabs, or funding; info@zenithTachyon.com for direct.
What is Zenith Tachyon Labs?
ZTL is a Texas S-Corp (est. 2025) building cloud-native SOTA AI tools for med's edge—empowering clinicians and researchers with secure, scalable insights that accelerate workflows and outpace diseases.
What makes ZTL's platform different?
Our patent-pending models deliver 95%+ accuracy on standard cloud infra (AWS/Render), HIPAA-compliant from day zero—rapid engineering for prototypes to pilots, no heavy hardware or legacy lock-in.
Are pilot opportunities available?
Yes—stealth pilots launching Jan 2026 with experts; apply via contact form or email us at info@zenithtachyon..com, targeting 5-10 sites by mid 2026 with diverse datasets for validation.
Contact ZTL?
Drop a vector via the form—reply in 48h on pilots, collabs, or funding; info@zenithTachyon.com for direct.